Novo Nordisk to cut insulin prices by up to 75%

Following Eli Lilly's lead, Novo Nordisk announced that it will cut prices on some of its insulin products. Starting in January 2024, there will be a 75% price cut for NovoLog and NovoLog Mix 70/30, while Novolin and Levemir vials and FlexPens will see cuts of 65%.